The MST1 serine-threonine kinase, a component of the RASSF1-LATS tumor suppressor network, is involved in cell proliferation and apoptosis and has been implicated in cancer. However, the physiologic role of MST1 in prostate cancer is not well understood. Here, we investigated the possibility of a biochemical and functional link between androgen receptor (AR) and MST1 signaling. We showed that MST1 forms a complex with, and antagonizes, AR transcriptional activity as demonstrated by coimmunoprecipitation (co-IP), promoter reporter analysis and molecular genetic methods.
Introduction
The serine-threonine kinase MST1 or STK4 (mammalian sterile STE20-like kinase 1), a homolog of Hippo (Hpo/hpo) in Drosophila, was originally identified as a pro-apoptotic protein (1) . MST1 is related to three paralogs (MST2, MST3, and MST4) with a conserved structure consisting of N-terminal catalytic (MST1-N) and C-terminal regulatory (MST1-C) domains and other functional sites, including caspase cleavage sites and nuclear export signals (2, 3) . MST1 or MST2 can be activated by autophosphorylation of a unique threonine residue (Thr-183 in MST1 and Thr-180 in MST2) in the activation loop or by caspase-3 cleavage in response to a wide range of cell death stimuli (4) .
In addition to their pro-apoptotic function, MST1 and its closest paralog MST2
have been demonstrated to play an important role in mammalian development (5, 6) , cell cycle progression and tumorigenesis (7) (8) (9) (10) . For example, hpo deficiency in the developing Drosophila eye results in massive overgrowth due to an accelerated rate of proliferation and failure of developmental apoptosis (11) (12) (13) . Likewise, MST1 or MST2 deficiency in mice is embryonically lethal (5) . Loss or reduction of MST1 and MST2 expression has also been correlated with poor cancer prognosis (14) . Recent genetic studies have indicated that liver-specific deletion of MST1 and MST2 in mice resulted in liver enlargement, cancer and resistance to TNF-α induced apoptosis (7, 9, 10) . Previous studies suggest that cross talk between androgen receptor (AR) and MST1 signaling may have important biological consequences in prostate cancer (PCa) (15, 16) . We wanted to Here we demonstrate that MST1 is a novel negative regulator of AR signaling.
Our data suggest that MST1 attenuates AR activity via a mechanism that involves protein complex formation between AR and MST1 in a manner that is independent of its kinase activity. Furthermore, we provide evidence that enforced MST1 expression suppressed PCa cell growth, sensitized androgen-independent C4-2 cells to PI3K inhibition, and attenuated tumor growth in vivo. These findings suggest that loss of MST1 signaling may promote hyperactivation of AR and may be associated with the emergence of the castration-resistant phenotype.
Materials and Methods

Plasmid Constructions, Antibodies and Reagents
The construction of HA-or Myc-tagged MST1-wt and Myc-MST1-N and Myc-MST1-C forms was described previously (15) . For the construction of Doxyclineinducible HA-MST1 plasmid, PCR-amplified HA-tagged MST1-wt cDNA was inserted into BamH1 and MluI enzyme sites in the pRetro-X-Pur vector (Clontech Laboratories, Inc., Mountain View, CA), designated as pRXTP-HA-MST1. The construction of GST-AR DBD/HR (AR DNA binding domain and hinge region) was described previously (17) . MST1 and AR point mutations were generated using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The orientation and fidelity of all constructs were confirmed by DNA sequencing. Note that names of antibodies and reagents and with a Plan-Apochromat oil immersion lens on an Axioplan 2 Apotome epifluorescence microscope (Zeiss, Germany). Immunohistochemistry (IHC) was performed using reagents from DAKO (Carpinteria, CA) and images were acquired at 20X with Nikon Imaging System (Japan).
Establishment of TetON-Inducible Cells
Retroviruses carrying Tet-repressor or HA-MST1 expression constructs were produced in HEK 293T cells expressing viral packaging proteins and then viral particles were concentrated using PEG-it solution. LNCaP parental cells or its castration-resistant subline, C4-2, were first infected with retrovirus encoding pRetroX-TetON advanced plasmid, followed by selection with Geneticin (G418, 500 μg/ml) to generate the TetON 
Protein Analyses
Cell lysis was performed in buffer consisting of 20 mM HEPES, pH 7.4, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, protease inhibitors and phosphatase inhibitor. For immunoprecipitation, cleared lysates were incubated with antibody overnight at 4 o C.
Antibody-antigen complexes were collected on Protein A-or G-sepharose and washed three times with cell lysis buffer. Immunoprecipitates were resolved by SDS-PAGE.
PBST (0.1% Tween-20) containing 5% (w/v) skim milk powder or PBST containing 5%
IgG free BSA (Sigma) was used in membrane blocking and antibody dilutions. Signals were visualized by chemiluminescence. GST-AR DBD/HR and its mutant forms were expressed in bacteria with IPTG induction and protein purification was performed with GST-sepharose using a standard protocol. Cytoplasmic and nuclear fractions were prepared as described (18) .
ChIP Assays
Chromatin Immunoprecipitation (ChIP) was performed as described previously (19) . Briefly, LNCaP or C4-2/HA-MST1 cells grown in serum-starved conditions were treated with R1881 (1 nM) or EtOH (vehicle) overnight. Dox -/+ used to induce MST1 
Kinase, Cell Death, and Cell Proliferation Assays
For in vitro kinase assay, the recombinant, pre-activated MST1 protein kinase was incubated with purified GST-AR DBD/HR fusion protein and 10 ȝCi 
Statistics
Data are represented as mean +/-SEM. Student t-test (2-tailed) was used between the data pairs where it is appropriate. A p-value less than or equal to 0.05 was considered significant.
Results
MST1 binds and attenuates AR activity
To determine whether the MST1 kinase biochemically and functionally intersects with AR signaling, we employed cellular and biochemical approaches using prostate and To test whether the binding of MST1 has an impact on AR activity, we conducted AR-dependent promoter-reporter assays (18, 21) using knockdown and induction approaches. MST1 knockdown by a gene-specific small interfering RNA (siRNA) (15) resulted in the upregulation of basal and androgen-stimulated AR-responsive PSA promoter reporter activation, by at least 2-fold in comparison to siRNA control ( Figure   1B To determine whether Ser-650 phosphorylation has a role in the attenuation of AR activity by MST1, we generated phosphorylation-inactivating (Ser→Ala) or phosphomimetic (Ser→Glu) mutations and assessed their impact on MST1-mediated inhibition of AR activity. The data in Figure 3C show that enforced-MST1 expression is capable of inhibiting AR transcriptional activity regardless of the presence of phosphorylation-inactivating S650A or phosphomimetic S650D AR mutations. Similarly, other site-specific phosphorylation-inactivating mutations did not significantly affect AR inhibition by MST1 induction (Supplementary Figure S3C) . In addition, phosphorylationinactivating or phosphomimetic mutations did not alter ligand-dependent nuclear localization of AR in COS-7 cells expressing exogenous AR ( Figure 3D ). Furthermore, co-IP/western blot analyses showed that neither type of mutation affected complex formation between the two proteins (Supplementary Figure S3D) . In addition, with the exception of the S308A mutation, these known phospho-site mutations do not significantly alter androgen-induced AR transcriptional activity in COS-7 cells (Supplementary Figure S4A) . These findings indicate that the phosphorylation of Ser-650 by MST1 is not involved in the mediation of AR inhibition by MST1.
MST1 kinase activity is not required for the inhibition of AR activity
To determine whether MST1 kinase activity has an effect on the inhibition of AR transcriptional activity, we generated kinase-deficient MST1 mutants (MST1-K59R in the ATP binding pocket and MST1-T183A in the activation loop). Consistent with published data (3), neither of these MST1 mutants was able to induce apoptosis in COS-7 or in LNCaP cells, compared to MST1-wt ( Figure 4A ). However, both mutants were capable of inhibiting AR-driven PSA promoter activation, similar to the levels observed with MST1-wt in LNCaP ( Figure 4B ) and in its castration-resistant C4-2 subline (Supplementary Figure S4B) . We then examined the protein complexes between AR and these kinase-inactivated MST1 mutants. Mock, MST1-wt, MST1-K59R, or MST1-T183A constructs were co-expressed with AR in COS-7 cells and co-IP experiments were performed using total cell lysates. Western blot analysis with anti-AR antibody revealed that the kinase-inactivating mutation had no affect on the formation of the AR and MST1 complex ( Figure 4C ). We also performed the promoter reporter assay with MST2 and demonstrated that transient expression of this close structural relative to 
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MST1 also antagonized the AR transactivation function in LNCaP cells independently of its kinase activity ( Figure 4D ). These results suggest that both kinases perform a similar inhibitory role with respect to the AR, and that neither the kinase activity nor the proapoptotic function of MST1 or MST2 is involved in the inhibition of AR activity.
MST1 suppresses AR activity by intersecting with AKT1 signaling and antagonizing formation of AR-chromatin complexes
An implication from the above findings is that additional mechanisms may be involved in MST1-mediated AR inhibition. MST1 was reported to inhibit AKT signaling (15) , which is known to functionally intersect with (16, 22) and promote AR-driven PSA promoter activation (23) . To test whether MST1 induction could suppress AR activation mediated by AKT1 signaling, we performed promoter-reporter assays and showed that enforced MST1 expression antagonized AKT1 mediated androgen-dependent andindependent AR activation ( Figure 5A, left panel) . Co-IP experiments further revealed that MST1, AR, and AKT1 form a tri-partite complex in vivo ( Figure 5A , right panel), indicating that MST1 also intersects with AKT signaling to attenuate AR activity.
Given that MST1 forms protein complexes with AR, we showed using co-IP experiments that endogenous AR and MST1 form a complex preferentially in cell nuclei ( Figure 5B ). These observations led us to investigate whether MST1 localizes within ARtranscriptional complexes. Chromatin immunoprecipitation (ChIP) experiments showed that endogenous MST1 interacts with the PSA promoter region, which also binds AR in both serum-and androgen free conditions and can be regulated androgen in LNCaP cells Figure 5C ). This segment of the PSA promoter, referred to as the androgen-responsive element enhancer (ARE) core, consists of multiple AREs and plays a prominent role in AR-driven PSA promoter regulation (18, 21) . Additional data suggest that MST1 also binds ARE-I and the TATA region in the PSA promoter, which can also be regulated by androgen ( Figure 5D ). Taken together, these findings suggest that MST1 reduces ARchromatin complex formation to attenuate androgenic signals.
MST1 suppresses PCa cell growth in vitro and tumor growth in vivo
To address the impact of MST1 on cell growth, we established stable MST1
expressing LNCaP/HA-MST1 or C4-2/HA-MST1 cells using a retroviral inducible system. LNCaP/HA-MST1 or C4-2/HA-MST1 cells were exposed to increasing doses of doxycycline (Dox). Dose-dependent induction of MST1 expression reduced the growth of LNCaP; however, castration-resistant LNCaP subline, C4-2, displayed resistance to the growth suppressive effects of enforced MST1 ( Figure 6A and B) . The observed growth reduction originated from MST1 induction because the administration of the highest dose of Dox (4 ȝg/ml), which reduced the growth of LNCaP/HA-MST1 the most, had no effect on the growth of LNCaP/Vector cells (Supplementary Figure S5A) . In addition, enforced MST1 expression in C4-2/HA-MST1 cells dramatically reduced the number and size of C4-2 colonies grown on soft agar ( Figure 6C ) and sensitized C4-2 cells to growth suppression induced by PI3K inhibitor LY294002 ( Figure 6D ). C4-2 cells are relatively resistant to PI3K inhibitors (24) and less sensitive to the effects of MST1 compared to parental LNCaP cells ( Figure 6A 
Discussion
In this study, we demonstrated that the serine-threonine kinase MST1 is a physiologic negative regulator of AR signaling. We provide evidence that MST1 forms protein complexes in vitro and in vivo with AR and antagonizes AR activity in multiple cell backgrounds. Although both the full-length MST1 and the cleaved MST1-N forms bound and inhibited AR activity, caspase-resistant MST1 was the most potent AR inhibitor. We found that the kinase activity of MST1 was not required for the attenuation of AR activity. Similarly, the pro-apoptotic function of MST1 is not involved in AR inhibition because kinase deficient MST1, which failed to induce cell death, was capable of interacting with AR and inhibiting AR transcriptional activity. expression, which was shown be correlated with hormone-refractory PCa (30) . On the other hand, phosphorylation of AR at Ser-650 by JNK1 or p38 MAP kinase was demonstrated to inhibit AR activity (17) . Here we showed that MST1 is an AR kinase and phosphorylates AR at Ser-650 ( Figure 3C ). However, phosphorylation of Ser-650 by MST1 had no effect on the observed inhibition of AR-transcriptional activity.
Nevertheless, the role of phospho-Ser650 on mechanisms of AR action deserves further investigation, given that phosphorylation-inactivating S650A or phosphomimetic S650D AR mutations are able to alter the cellular distribution of AR in comparison to that observed with AR-wt under androgen-free conditions ( Figure 3D ). Our data do not rule out the possibility that the existence of other potential MST1 phosphorylation sites might play a role in the inhibition of AR activity by MST1. In addition, the induction of MST1 was shown to activate JNK1 (32), which is known to inhibit AR (17). We did not observe JNK1 activation in response to MST1 induction in LNCaP, unless cells were treated with phorbol ester (Supplementary Figure S2C) . This indicates that MST1 attenuates AR signaling by a distinct mechanism apart from JNK or p38 MAP kinase activation.
In addition to post-translational modifications, transcriptional co-regulators (i.e. co-repressors or co-activators) play an essential role in the modulation of AR activity, and their altered expression has been demonstrated in prostate tumor progression (33) .
For example, the recruitment of nuclear co-repressor (N-CoR) (34) or silencing mediator for thyroid and retinoid receptors (SMRT) (35) into the AR transcriptional complex was shown to antagonize AR activity by a mechanism involving protein-protein interaction.
Similarly, displacement of co-activators such as p300 from the holo-AR transcriptional complex, or recruitment to the complex of histone deacetylase (HDAC), which modifies 
chromatin structure to a transcriptionally inactive form (36) , have also been shown to attenuate AR activity (35) . Given that MST1 attenuates AR activity by forming protein complexes, the localization of MST1 into the holo-AR transcriptional complex could also attenuate the AR. Our data in Figure 5C and 5D and Figure 7B support this conclusion; however, comprehensive studies are needed to elucidate precisely how MST1 alters ARchromatin complexes.
MST1 and its downstream effectors, such as WW45 or LATS1/2, have been implicated in cancer, including PCa (37) . For example, the liver specific knockout of MST1/2 expression in mice has been associated with hepatocellular carcinoma, which has been linked to the activation of YAP (7, 9, 10) , and YAP is normally attenuated by the MST-LATS signaling network (10) . The loss or reduced expression of LATS2 was reported in PCa and this was shown to be associated with hyperactivation of AR and upregulation of AR-dependent gene expression (38) , with protein products known to promote PCa cell survival and inhibit apoptosis. In addition, mice lacking WW45 expression displayed hyperplasia in several organ sites (39). Here we found that the induction of MST1 expression is sufficient to antagonize AR-driven gene expression and suppress PCa cell growth. Moreover, we found that the growth suppressive effects of 
induction of MST1 expression sensitized C4-2 cells to growth suppression induced by PI3K inhibition. Our findings raise the possibility that deregulated-MST function may be associated with the emergence of the castration-resistant disease phenotype. The use of MST1/2 knockout mouse models will address the hypothesis of whether one or both of these kinases have a direct role in prostate carcinogenesis and emergence of castrationresistance.
PCa is the most commonly diagnosed cancer among men and the second leading cause of cancer death in Western countires (40, 41) . Evidence indicates that cooperative AR and PI3K/AKT-mTOR pathway signaling is critical to human prostate tumor development and progression to the metastatic phenotype (42) (43) (44) . Based on published studies (15, 16) and our present findings, we propose a model ( Figure 7D 
